{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:55:19Z","timestamp":1776254119233,"version":"3.50.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00223245"],"award-info":[{"award-number":["RS-2023-00223245"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR066818"],"award-info":[{"award-number":["RS-2022-NR066818"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41159-1","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:53:57Z","timestamp":1772808837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug target mining and in silico screening of Tibetan plant metabolites for potential alleviation of Oroya fever, a neglected tropical disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Zarrin","family":"Basharat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsheen","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan A.","family":"Ogaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah A. M.","family":"Al-Zahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufaq","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin R.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Jadoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"41159_CR1","doi-asserted-by":"publisher","first-page":"e2919","DOI":"10.1371\/journal.pntd.0002919","volume":"8","author":"MF Minnick","year":"2014","unstructured":"Minnick, M. F. et al. Oroya fever and verruga peruana: bartonelloses unique to South America. PLoS Negl. Trop. Dis. 8, e2919 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"41159_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21608\/jesp.2023.297342","volume":"53","author":"TA Morsy","year":"2023","unstructured":"Morsy, T. A., Hawam, S. M., Hadidy, H. A. E. & Ahmed, S. A. M. Zoonotic bartonellosis: Is it threrating to the eastern mediterranean countries?. J. Egypt. Soc. Parasitol. 53, 35\u201350 (2023).","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"41159_CR3","first-page":"707","volume":"92","author":"W Saisongkorh","year":"2011","unstructured":"Saisongkorh, W., Rolain, J.-M., Suputtamongkol, Y. & Raoult, D. Emerging Bartonella in humans and animals in Asia and Australia. J. Med. Assoc. Thai. 92, 707 (2011).","journal-title":"J. Med. Assoc. Thai."},{"key":"41159_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetimm.2008.01.025","volume":"123","author":"EB Breitschwerdt","year":"2008","unstructured":"Breitschwerdt, E. B. Feline bartonellosis and cat scratch disease. Vet. Immunol. Immunopathol. 123, 167\u2013171 (2008).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"41159_CR5","unstructured":"Ramela, A.-D. Investigating the impact of the FIC domain Bartonella quintana effector protein, BepA1, on human innate immune responses Masters thesis, Open Access Te Herenga Waka-Victoria University of Wellington, (2022)."},{"key":"41159_CR6","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1016\/S2666-5247(21)00184-1","volume":"2","author":"AA Dichter","year":"2021","unstructured":"Dichter, A. A. et al. Identification of immunodominant Bartonella bacilliformis proteins: A combined in-silico and serology approach. Lancet Microbe 2, e685\u2013e694 (2021).","journal-title":"Lancet Microbe"},{"key":"41159_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.abd.2019.09.024","volume":"94","author":"KdA Lins","year":"2019","unstructured":"Lins, Kd. A., Drummond, M. R. & Velho, P. E. N. F. Cutaneous manifestations of bartonellosis. An. Bras. Dermatol. 94, 594\u2013602 (2019).","journal-title":"An. Bras. Dermatol."},{"key":"41159_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/CMR.00013-17","volume":"30","author":"U Okaro","year":"2017","unstructured":"Okaro, U., Addisu, A., Casanas, B. & Anderson, B. Bartonella species, an emerging cause of blood-culture-negative endocarditis. Clin. Microbiol. Rev. 30, 709\u2013746. https:\/\/doi.org\/10.1128\/CMR.00013-17 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"41159_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1084\/jem.193.9.1077","volume":"193","author":"R Sch\u00fclein","year":"2001","unstructured":"Sch\u00fclein, R. et al. Invasion and persistent intracellular colonization of erythrocytes: a unique parasitic strategy of the emerging pathogen Bartonella. J. Exp. Med. 193, 1077\u20131086 (2001).","journal-title":"J. Exp. Med."},{"key":"41159_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/CMR.05009-11","volume":"25","author":"A Harms","year":"2012","unstructured":"Harms, A. & Dehio, C. Intruders below the radar: Molecular pathogenesis of Bartonella spp. Clin. Microbiol. Rev. 25, 42\u201378 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"41159_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00056-00017","author":"C Gomes","year":"2018","unstructured":"Gomes, C. & Ruiz, J. Carrion\u2019s disease: The sound of silence. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/cmr.00056-00017 (2018).","journal-title":"Clin. Microbiol. Rev."},{"key":"41159_CR12","unstructured":"Paradela Gomes, C. S. Antimicrobial resistance and new insights in the diagnosis of Carri\u00f3n's Disease Doctoral thesis, University of Barcelona, (2016)."},{"key":"41159_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/jac\/dkm105","volume":"59","author":"S Biswas","year":"2007","unstructured":"Biswas, S., Raoult, D. & Rolain, J.-M. Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis. J. Antimicrob. Chemother. 59, 1065\u20131070 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"41159_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijantimicag.2008.03.017","volume":"32","author":"S Biswas","year":"2008","unstructured":"Biswas, S., Raoult, D. & Rolain, J.-M. A bioinformatic approach to understanding antibiotic resistance in intracellular bacteria through whole genome analysis. Int. J. Antimicrob. Agents 32, 207\u2013220 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"41159_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/9781444308464.ch10","volume-title":"Staphylococci in Human Disease","author":"J Strahilevitz","year":"2009","unstructured":"Strahilevitz, J. & Hooper, D. C. Resistance to other agents. In Staphylococci in Human Disease 210\u2013234 (Wiley-Blackwell, 2009)."},{"key":"41159_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/antibiotics8040246","volume":"8","author":"X Ma","year":"2019","unstructured":"Ma, X., Shi, W. & Zhang, Y. Essential oils with high activity against stationary phase Bartonella henselae. Antibiotics 8, 246 (2019).","journal-title":"Antibiotics"},{"key":"41159_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/IM9.0000000000000069","volume":"3","author":"X Ma","year":"2021","unstructured":"Ma, X., Leone, J., Schweig, S. & Zhang, Y. Botanical medicines with activity against stationary phase Bartonella henselae. Infect. Microbes Dis. 3, 158\u2013167 (2021).","journal-title":"Infect. Microbes Dis."},{"key":"41159_CR18","doi-asserted-by":"publisher","DOI":"10.1515\/9780295743004","volume-title":"Medicine and Memory in Tibet: Amchi Physicians in an Age of Reform","author":"T Hofer","year":"2018","unstructured":"Hofer, T. Medicine and Memory in Tibet: Amchi Physicians in an Age of Reform (University of Washington Press, 2018)."},{"key":"41159_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ph17010022","volume":"17","author":"SK Niazi","year":"2023","unstructured":"Niazi, S. K. & Mariam, Z. Computer-aided drug design and drug discovery: A prospective analysis. Pharmaceuticals 17, 22 (2023).","journal-title":"Pharmaceuticals"},{"key":"41159_CR20","first-page":"523","volume-title":"New Look to Phytomedicine","author":"A Dhasmana","year":"2019","unstructured":"Dhasmana, A., Raza, S., Jahan, R., Lohani, M. & Arif, J. M. High-throughput virtual screening (HTVS) of natural compounds and exploration of their biomolecular mechanisms. In New Look to Phytomedicine 523\u2013548 (Elsevier, 2019)."},{"key":"41159_CR21","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2174\/1568026618666181025114157","volume":"18","author":"AA Naqvi","year":"2018","unstructured":"Naqvi, A. A., Mohammad, T., Hasan, G. M. & Hassan, M. I. Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem. 18, 1755\u20131768 (2018).","journal-title":"Curr. Top. Med. Chem."},{"key":"41159_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4155\/fmc.13.202","volume":"6","author":"F Schmidt","year":"2014","unstructured":"Schmidt, F., Matter, H., Hessler, G. & Czich, A. Predictive in silico off-target profiling in drug discovery. Future Med. Chem. 6, 295\u2013317 (2014).","journal-title":"Future Med. Chem."},{"key":"41159_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/toxics11100875","volume":"11","author":"M Rao","year":"2023","unstructured":"Rao, M., McDuffie, E. & Sachs, C. Artificial Intelligence\/Machine learning-driven small molecule repurposing via off-target prediction and transcriptomics. Toxics 11, 875 (2023).","journal-title":"Toxics"},{"key":"41159_CR24","doi-asserted-by":"publisher","first-page":"eaaw8412","DOI":"10.1126\/scitranslmed.aaw8412","volume":"11","author":"A Lin","year":"2019","unstructured":"Lin, A. et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci. Transl. Med. 11, eaaw8412 (2019).","journal-title":"Sci. Transl. Med."},{"key":"41159_CR25","doi-asserted-by":"publisher","first-page":"D678","DOI":"10.1093\/nar\/gkac1003","volume":"51","author":"RD Olson","year":"2023","unstructured":"Olson, R. D. et al. Introducing the bacterial and viral bioinformatics resource center (BV-BRC): a resource combining PATRIC. IRD and ViPR. Nucleic Acids Res. 51, D678\u2013D689 (2023).","journal-title":"IRD and ViPR. Nucleic Acids Res."},{"key":"41159_CR26","doi-asserted-by":"publisher","first-page":"24373","DOI":"10.1038\/srep24373","volume":"6","author":"NM Chaudhari","year":"2016","unstructured":"Chaudhari, N. M., Gupta, V. K. & Dutta, C. BPGA-an ultra-fast pan-genome analysis pipeline. Sci. Rep. 6, 24373 (2016).","journal-title":"Sci. Rep."},{"key":"41159_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ygeno.2020.12.015","volume":"113","author":"Z Basharat","year":"2021","unstructured":"Basharat, Z., Jahanzaib, M., Yasmin, A. & Khan, I. A. Pan-genomics, drug candidate mining and ADMET profiling of natural product inhibitors screened against Yersinia pseudotuberculosis. Genomics 113, 238\u2013244 (2021).","journal-title":"Genomics"},{"key":"41159_CR28","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","volume":"28","author":"L Fu","year":"2012","unstructured":"Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: Accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150\u20133152 (2012).","journal-title":"Bioinformatics"},{"key":"41159_CR29","doi-asserted-by":"publisher","first-page":"D677","DOI":"10.1093\/nar\/gkaa917","volume":"49","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. DEG 15, an update of the database of essential genes that includes built-in analysis tools. Nucleic Acids Res. 49, D677\u2013D686 (2021).","journal-title":"Nucleic Acids Res."},{"key":"41159_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-769","volume":"14","author":"Y-N Ye","year":"2013","unstructured":"Ye, Y.-N., Hua, Z.-G., Huang, J., Rao, N. & Guo, F.-B. CEG: A database of essential gene clusters. BMC Genomics 14, 1\u201310 (2013).","journal-title":"BMC Genomics"},{"key":"41159_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10142-023-01179-w","volume":"23","author":"A Khan","year":"2023","unstructured":"Khan, A. et al. Exploring and targeting potential druggable antimicrobial resistance targets ArgS, SecY, and MurA in Staphylococcus sciuri with TCM inhibitors through a subtractive genomics strategy. Funct. Integr. Genom. 23, 254 (2023).","journal-title":"Funct. Integr. Genom."},{"key":"41159_CR32","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"41159_CR33","doi-asserted-by":"crossref","unstructured":"Charoenkwan, P., Schaduangrat, N., Moni, M. A., Shoombuatong, W. & Manavalan, B. Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework. iScience 25 (2022).","DOI":"10.1016\/j.isci.2022.104883"},{"key":"41159_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/prot.21018","volume":"64","author":"CS Yu","year":"2006","unstructured":"Yu, C. S., Chen, Y. C., Lu, C. H. & Hwang, J. K. Prediction of protein subcellular localization. Proteins 64, 643\u2013651 (2006).","journal-title":"Proteins"},{"key":"41159_CR35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The proteomics protocols handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger, E. et al. The proteomics protocols handbook 571\u2013607 (Springer, 2005)."},{"key":"41159_CR36","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/S0006-3495(99)77389-3","volume":"76","author":"AFP de Araujo","year":"1999","unstructured":"de Araujo, A. F. P., Pochapsky, T. C. & Joughin, B. Thermodynamics of interactions between amino acid side chains: Experimental differentiation of aromatic-aromatic, aromatic-aliphatic, and aliphatic-aliphatic side-chain interactions in water. Biophys. J. 76, 2319\u20132328 (1999).","journal-title":"Biophys. J."},{"key":"41159_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s13205-023-03720-x","volume":"13","author":"D Hu","year":"2023","unstructured":"Hu, D., Long, X., Luobu, T. & Wang, Q. Current status of research on endophytes of traditional Tibetan medicinal plant and their metabolites. 3 Biotech 13, 338 (2023).","journal-title":"3 Biotech"},{"key":"41159_CR38","doi-asserted-by":"publisher","first-page":"154074","DOI":"10.1016\/j.jplph.2023.154074","volume":"288","author":"R Li","year":"2023","unstructured":"Li, R. et al. Insights into the mechanism underlying UV-B induced flavonoid metabolism in callus of a Tibetan medicinal plant Mirabilis himalaica. J. Plant Physiol. 288, 154074 (2023).","journal-title":"J. Plant Physiol."},{"key":"41159_CR39","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/life12111743","volume":"12","author":"Z Basharat","year":"2022","unstructured":"Basharat, Z. et al. Inferring therapeutic targets in candida albicans and possible inhibition through natural products: a binding and physiological based pharmacokinetics snapshot. Life 12, 1743 (2022).","journal-title":"Life"},{"key":"41159_CR40","doi-asserted-by":"crossref","unstructured":"Basharat, Z. & Khoso, A. Neglected tropical diseases phytochemicals in drug discovery 397-415 (2021).","DOI":"10.1002\/9781119617143.ch16"},{"key":"41159_CR41","doi-asserted-by":"publisher","first-page":"167208","DOI":"10.1016\/j.jmb.2021.167208","volume":"433","author":"KM Ruff","year":"2021","unstructured":"Ruff, K. M. & Pappu, R. V. AlphaFold and implications for intrinsically disordered proteins. J. Mol. Biol. 433, 167208 (2021).","journal-title":"J. Mol. Biol."},{"key":"41159_CR42","first-page":"1000","volume":"10550","author":"R Huey","year":"2012","unstructured":"Huey, R., Morris, G. M. & Forli, S. Using AutoDock 4 and AutoDock vina with AutoDockTools: a tutorial. Scripps Res. Inst. Mol. Graphics Lab. 10550, 1000 (2012).","journal-title":"Scripps Res. Inst. Mol. Graphics Lab."},{"key":"41159_CR43","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/wcms.1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan, S., Chan, H. S. & Hu, Z. Using PyMOL as a platform for computational drug design. Wiley Interdiscip. Rev. Comput. Mol. Sci. 7, e1298 (2017).","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"41159_CR44","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme, M. F. et al. PLIP 2021: Expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 49, W530\u2013W534 (2021).","journal-title":"Nucleic Acids Res."},{"key":"41159_CR45","unstructured":"Corso, G., St\u00e4rk, H., Jing, B., Barzilay, R. & Jaakkola, T. Diffdock: Diffusion steps, twists, and turns for molecular docking. Preprint at arXiv, 01776 (2022)."},{"key":"41159_CR46","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.3390\/molecules26237369","volume":"26","author":"J Sunseri","year":"2021","unstructured":"Sunseri, J. & Koes, D. R. Virtual screening with Gnina 1.0. Molecules 26, 7369 (2021).","journal-title":"Molecules"},{"key":"41159_CR47","doi-asserted-by":"publisher","first-page":"e0155183","DOI":"10.1371\/journal.pone.0155183","volume":"11","author":"R Quiroga","year":"2016","unstructured":"Quiroga, R. & Villarreal, M. A. Vinardo: A scoring function based on autodock vina improves scoring, docking, and virtual screening. PLoS ONE 11, e0155183 (2016).","journal-title":"PLoS ONE"},{"key":"41159_CR48","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"41159_CR49","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"41159_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1124\/dmd.121.000552","volume":"50","author":"A-K Sohlenius-Sternbeck","year":"2022","unstructured":"Sohlenius-Sternbeck, A.-K. & Terelius, Y. Evaluation of ADMET predictor in early discovery drug metabolism and pharmacokinetics project work. Drug Metab. Dispos. 50, 95\u2013104 (2022).","journal-title":"Drug Metab. Dispos."},{"key":"41159_CR51","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","volume":"32","author":"MV Varma","year":"2015","unstructured":"Varma, M. V., Steyn, S. J., Allerton, C. & El-Kattan, A. F. Predicting clearance mechanism in drug discovery: Extended clearance classification system (ECCS). Pharm. Res. 32, 3785\u20133802 (2015).","journal-title":"Pharm. Res."},{"key":"41159_CR52","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1124\/dmd.117.080044","volume":"46","author":"AF El-Kattan","year":"2018","unstructured":"El-Kattan, A. F. & Varma, M. V. Navigating transporter sciences in pharmacokinetics characterization using the extended clearance classification system. Drug Metab. Dispos. 46, 729\u2013739 (2018).","journal-title":"Drug Metab. Dispos."},{"key":"41159_CR53","doi-asserted-by":"publisher","first-page":"bbad419","DOI":"10.1093\/bib\/bbad419","volume":"25","author":"J Dong","year":"2024","unstructured":"Dong, J., Wu, Z., Xu, H. & Ouyang, D. FormulationAI: A novel web-based platform for drug formulation design driven by artificial intelligence. Brief. Bioinform. 25, bbad419 (2024).","journal-title":"Brief. Bioinform."},{"key":"41159_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejps.2012.06.013","volume":"47","author":"AT Heikkinen","year":"2012","unstructured":"Heikkinen, A. T., Baneyx, G., Caruso, A. & Parrott, N. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates\u2013an evaluation and case study using GastroPlus\u2122. Eur. J. Pharm. Sci. 47, 375\u2013386 (2012).","journal-title":"Eur. J. Pharm. Sci."},{"key":"41159_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10604-y","author":"Z Basharat","year":"2023","unstructured":"Basharat, Z., Murtaza, Z., Siddiqa, A., Alnasser, S. M. & Meshal, A. Therapeutic target mapping from the genome of Kingella negevensis and biophysical inhibition assessment through PNP synthase binding with traditional medicinal compounds. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-023-10604-y (2023).","journal-title":"Mol. Divers."},{"key":"41159_CR56","volume-title":"Seminars in Perinatology","author":"EA Pinheiro","year":"2020","unstructured":"Pinheiro, E. A. & Stika, C. S. Seminars in Perinatology (Elsevier, 2020)."},{"key":"41159_CR57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/cpt.757","volume":"102","author":"JO Miners","year":"2017","unstructured":"Miners, J. O., Yang, X., Knights, K. M. & Zhang, L. The role of the kidney in drug elimination: Transport, metabolism, and the impact of kidney disease on drug clearance. Clin. Pharmacol. Ther. 102, 436\u2013449 (2017).","journal-title":"Clin. Pharmacol. Ther."},{"key":"41159_CR58","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2215\/CJN.01290308","volume":"3","author":"LS Dalrymple","year":"2008","unstructured":"Dalrymple, L. S. & Go, A. S. Epidemiology of acute infections among patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1487\u20131493 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"41159_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11095-024-03664-8","volume":"41","author":"J Adiwidjaja","year":"2024","unstructured":"Adiwidjaja, J., Spires, J. & Brouwer, K. L. Physiologically based Pharmacokinetic (PBPK) model predictions of disease mediated changes in drug disposition in patients with nonalcoholic fatty liver disease (NAFLD). Pharm. Res. 41, 441\u2013462 (2024).","journal-title":"Pharm. Res."},{"key":"41159_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"41159_CR61","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.3390\/molecules28207176","volume":"28","author":"I Boulos","year":"2023","unstructured":"Boulos, I. et al. Exploring the world of membrane proteins: techniques and methods for understanding structure, function, and dynamics. Molecules 28, 7176 (2023).","journal-title":"Molecules"},{"key":"41159_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10969-010-9088-5","volume":"11","author":"C Kim","year":"2010","unstructured":"Kim, C. et al. An automated pipeline to screen membrane protein 2D crystallization. J. Struct. Funct. Genomics 11, 155\u2013166 (2010).","journal-title":"J. Struct. Funct. Genomics"},{"key":"41159_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1042\/EBC20160064","volume":"61","author":"M Chitsaz","year":"2017","unstructured":"Chitsaz, M. & Brown, M. H. The role played by drug efflux pumps in bacterial multidrug resistance. Essays Biochem. 61, 127\u2013139 (2017).","journal-title":"Essays Biochem."},{"key":"41159_CR64","doi-asserted-by":"publisher","first-page":"723274","DOI":"10.3389\/fmolb.2021.723274","volume":"8","author":"M Pasqua","year":"2021","unstructured":"Pasqua, M. et al. Host-bacterial pathogen communication: the wily role of the multidrug efflux pumps of the MFS family. Front. Mol. Biosci. 8, 723274 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"41159_CR65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.tips.2008.04.001","volume":"29","author":"KB Wallace","year":"2008","unstructured":"Wallace, K. B. Mitochondrial off targets of drug therapy. Trends Pharmacol. Sci. 29, 361\u2013366 (2008).","journal-title":"Trends Pharmacol. Sci."},{"key":"41159_CR66","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.3390\/ijms21093118","volume":"21","author":"GV Mechetin","year":"2020","unstructured":"Mechetin, G. V., Endutkin, A. V., Diatlova, E. A. & Zharkov, D. O. Inhibitors of DNA glycosylases as prospective drugs. Int. J. Mol. Sci. 21, 3118 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"41159_CR67","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fbioe.2020.570828","volume":"8","author":"LA Averianova","year":"2020","unstructured":"Averianova, L. A., Balabanova, L. A., Son, O. M., Podvolotskaya, A. B. & Tekutyeva, L. A. Production of vitamin B2 (riboflavin) by microorganisms: An overview. Front. Bioeng. Biotechnol. 8, 1172 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"41159_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-323-66162-1.00011-1","volume-title":"Present Knowledge in Nutrition","author":"AHJ Merrill","year":"2020","unstructured":"Merrill, A. H. J. & McCormick, D. B. Riboflavin. In Present Knowledge in Nutrition 189\u2013207 (Elsevier, 2020)."},{"key":"41159_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymben.2021.08.009","volume":"68","author":"J You","year":"2021","unstructured":"You, J. et al. Microbial production of riboflavin: Biotechnological advances and perspectives. Metab. Eng. 68, 46\u201358 (2021).","journal-title":"Metab. Eng."},{"key":"41159_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/jof4020072","volume":"4","author":"Z Meir","year":"2018","unstructured":"Meir, Z. & Osherov, N. Vitamin biosynthesis as an antifungal target. J. Fungi 4, 72 (2018).","journal-title":"J. Fungi"},{"key":"41159_CR71","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/1573406413666171103093235","volume":"14","author":"A Sharma","year":"2018","unstructured":"Sharma, A., Jain, K. & Flora, S. J. Vitamins based novel target pathways\/molecules as possible emerging drug targets for the management of Tuberculosis. Med. Chem. 14, 212\u2013224 (2018).","journal-title":"Med. Chem."},{"key":"41159_CR72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s11030-022-10455-z","volume":"27","author":"K Jalal","year":"2023","unstructured":"Jalal, K. et al. Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase. Mol. Divers. 27, 793\u2013810 (2023).","journal-title":"Mol. Divers."},{"key":"41159_CR73","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1515\/bmc.2010.022","volume":"1","author":"SA Hollingsworth","year":"2010","unstructured":"Hollingsworth, S. A. & Karplus, P. A. A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins. Biomol. Concepts 1, 271\u2013283 (2010).","journal-title":"Biomol. Concepts"},{"key":"41159_CR74","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.str.2022.08.004","volume":"30","author":"C Shao","year":"2022","unstructured":"Shao, C., Bittrich, S., Wang, S. & Burley, S. K. Assessing PDB macromolecular crystal structure confidence at the individual amino acid residue level. Structure 30, 1385-1394. e1383 (2022).","journal-title":"Structure"},{"key":"41159_CR75","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1038\/s41598-022-14382-9","volume":"12","author":"H-B Guo","year":"2022","unstructured":"Guo, H.-B. et al. AlphaFold2 models indicate that protein sequence determines both structure and dynamics. Sci. Rep. 12, 10696 (2022).","journal-title":"Sci. Rep."},{"key":"41159_CR76","doi-asserted-by":"crossref","unstructured":"Das, O., Ghate, V. M. & Lewis, S. A. Utility of Sulfobutyl Ether \u03b2-Cyclodextrin inclusion complexes in drug delivery: A Review. Indian Journal of Pharmaceutical Sciences 81 (2019).","DOI":"10.36468\/pharmaceutical-sciences.549"},{"key":"41159_CR77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/d12080289","volume":"12","author":"M Nikolaidis","year":"2020","unstructured":"Nikolaidis, M., Dimitris, M., Oliver, S. G. & Amoutzias, G. D. Comparative analysis of the core proteomes among the Pseudomonas major evolutionary groups reveals species-specific adaptations for Pseudomonas aeruginosa and Pseudomonas chlororaphis. Diversity 12, 289. https:\/\/doi.org\/10.3390\/d12080289 (2020).","journal-title":"Diversity"},{"key":"41159_CR78","doi-asserted-by":"publisher","first-page":"1243987","DOI":"10.3389\/fmicb.2023.1243987","volume":"14","author":"L Li","year":"2023","unstructured":"Li, L. et al. AI-driven pan-proteome analyses reveal insights into the biohydrometallurgical properties of Acidithiobacillia. Front. Microbiol. 14, 1243987. https:\/\/doi.org\/10.3389\/fmicb.2023.1243987 (2023).","journal-title":"Front. Microbiol."},{"key":"41159_CR79","doi-asserted-by":"crossref","unstructured":"Harke, A. S. et al. Genomic insights into Lactobacillaceae: Analyzing the Alleleome of core pangenomes for enhanced understanding of strain diversity and revealing Phylogroup-specific unique variants. Preprint at bioRxiv, 2023.2009. 2022.558971 (2023).","DOI":"10.1101\/2023.09.22.558971"},{"key":"41159_CR80","doi-asserted-by":"publisher","first-page":"10011","DOI":"10.1016\/j.crmicr.2022.100111","volume":"3","author":"N Farah","year":"2022","unstructured":"Farah, N. et al. Riboflavin as a promising antimicrobial agent? A multi-perspective review. Curr. Res. Microb. Sci. 3, 10011. https:\/\/doi.org\/10.1016\/j.crmicr.2022.100111 (2022).","journal-title":"Curr. Res. Microb. Sci."},{"key":"41159_CR81","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/jb\/mvr095","volume":"150","author":"Y Moriyama","year":"2011","unstructured":"Moriyama, Y. Riboflavin transporter is finally identified. J. Biochem. 150, 341\u2013343. https:\/\/doi.org\/10.1093\/jb\/mvr095 (2011).","journal-title":"J. Biochem."},{"key":"41159_CR82","doi-asserted-by":"publisher","first-page":"101270","DOI":"10.1016\/j.jksus.2020.101270","volume":"33","author":"SNAM Aris","year":"2021","unstructured":"Aris, S. N. A. M. et al. Identification of potential riboflavin synthase inhibitors by virtual screening and molecular dynamics simulation studies. J. King Saud Univ.Sci. 33, 101270 (2021).","journal-title":"J. King Saud Univ.Sci."},{"key":"41159_CR83","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.3390\/cancers14246260","volume":"14","author":"NA Alturki","year":"2022","unstructured":"Alturki, N. A. et al. Therapeutic target identification and inhibitor screening against riboflavin synthase of colorectal cancer associated fusobacterium nucleatum. Cancers 14, 6260 (2022).","journal-title":"Cancers"},{"key":"41159_CR84","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1080\/07391102.2023.2208229","volume":"42","author":"Z Basharat","year":"2024","unstructured":"Basharat, Z. et al. Subtractive sequence-mediated therapeutic targets from the conserved gene clusters of Campylobacter hyointestinalis and computational inhibition assessment. J. Biomol. Struct. Dyn. 42, 2782\u20132792 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"41159_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1746-4269-5-15","volume":"5","author":"Y Liu","year":"2009","unstructured":"Liu, Y., Dao, Z., Yang, C., Liu, Y. & Long, C. Medicinal plants used by Tibetans in Shangri-la, Yunnan, China. J. Ethnobiol. Ethnomed. 5, 15. https:\/\/doi.org\/10.1186\/1746-4269-5-15 (2009).","journal-title":"J. Ethnobiol. Ethnomed."},{"key":"41159_CR86","doi-asserted-by":"publisher","first-page":"100927","DOI":"10.1016\/j.eujim.2019.100927","volume":"29","author":"K Yeshi","year":"2019","unstructured":"Yeshi, K. et al. An integrated medicine of Bhutan: Sowa Rigpa concepts, botanical identification, and the recorded phytochemical and pharmacological properties of the eastern Himalayan medicinal plants. Eur. J. Integr. Med. 29, 100927 (2019).","journal-title":"Eur. J. Integr. Med."},{"key":"41159_CR87","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.4155\/fmc-2018-0235","volume":"10","author":"D-C Hao","year":"2018","unstructured":"Hao, D.-C., Xiao, P.-G. & Liu, C. Traditional Tibetan medicinal plants: A highlighted resource for novel therapeutic compounds. Future Med. Chem. 10, 2537\u20132555 (2018).","journal-title":"Future Med. Chem."},{"key":"41159_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fphar.2018.00029","volume":"9","author":"Q Li","year":"2018","unstructured":"Li, Q. et al. Natural medicines used in the traditional Tibetan medical system for the treatment of liver diseases. Front. Pharmacol. 9, 29 (2018).","journal-title":"Front. Pharmacol."},{"key":"41159_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1746-4269-5-15","volume":"5","author":"Y Liu","year":"2009","unstructured":"Liu, Y., Dao, Z., Yang, C., Liu, Y. & Long, C. Medicinal plants used by Tibetans in Shangri-la, Yunnan, China. J. Ethnobiol. Ethnomed. 5, 15 (2009).","journal-title":"J. Ethnobiol. Ethnomed."},{"key":"41159_CR90","first-page":"00172","volume":"6","author":"K Rawat","year":"2017","unstructured":"Rawat, K., Prasad, K. & Bisht, G. Phytochemical analysis and antioxidant activity essential oil of Anaphalis contorta from Uttrakhand Himalayas. Analytical Pharma. Res. 6, 00172 (2017).","journal-title":"Analytical Pharma. Res."},{"key":"41159_CR91","first-page":"1934578X1300800","volume":"8","author":"RK Joshi","year":"2013","unstructured":"Joshi, R. K. Essential oil of flowers of Anaphalis contorta, an aromatic and medicinal plant from India. Nat. Prod. Commun. 8, 1934578X1300800224 (2013).","journal-title":"Nat. Prod. Commun."},{"key":"41159_CR92","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.3390\/molecules27217469","volume":"27","author":"H Wang","year":"2022","unstructured":"Wang, H., Xuan, M., Huang, C. & Wang, C. Advances in research on bioactivity, toxicity, metabolism, and pharmacokinetics of usnic acid in vitro and in vivo. Molecules 27, 7469 (2022).","journal-title":"Molecules"},{"key":"41159_CR93","first-page":"627","volume":"19","author":"JK Kim","year":"2020","unstructured":"Kim, J. K. & Park, S. U. Recent studies on kaempferol and its biological and pharmacological activities. EXCLI J. 19, 627 (2020).","journal-title":"EXCLI J."},{"key":"41159_CR94","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1038\/s41598-025-95280-8","volume":"15","author":"Y Wu","year":"2025","unstructured":"Wu, Y. et al. NOTCH pathway was involved in Kaempferol 3-O-gentiobioside attenuated airway inflammation and mucus hypersecretion. Sci. Rep. 15, 10383 (2025).","journal-title":"Sci. Rep."},{"key":"41159_CR95","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainresbull.2016.04.002","volume":"125","author":"T Ahmed","year":"2016","unstructured":"Ahmed, T. et al. Ginsenoside Rb1 as a neuroprotective agent: A review. Brain Res. Bull. 125, 30\u201343. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.002 (2016).","journal-title":"Brain Res. Bull."},{"key":"41159_CR96","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S1875-5364(20)60032-2","volume":"18","author":"YH Yang","year":"2020","unstructured":"Yang, Y. H., Mao, J. W. & Tan, X. L. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel. Chin. J. Nat. Med. 18, 890\u2013897. https:\/\/doi.org\/10.1016\/S1875-5364(20)60032-2 (2020).","journal-title":"Chin. J. Nat. Med."},{"key":"41159_CR97","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1016\/j.bmc.2005.02.049","volume":"13","author":"A Billich","year":"2005","unstructured":"Billich, A. et al. Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight. Bioorg. Med. Chem. 13, 3157\u20133167 (2005).","journal-title":"Bioorg. Med. Chem."},{"key":"41159_CR98","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.theochem.2009.09.011","volume":"916","author":"M Remko","year":"2009","unstructured":"Remko, M. Molecular structure, lipophilicity, solubility, absorption, and polar surface area of novel anticoagulant agents. J. Mol. Struct. THEOCHEM 916, 76\u201385 (2009).","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"41159_CR99","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s11095-021-03048-2","volume":"38","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Molecular, solid-state and surface structures of the conformational polymorphic forms of ritonavir in relation to their physicochemical properties. Pharm. Res. 38, 971\u2013990 (2021).","journal-title":"Pharm. Res."},{"key":"41159_CR100","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/17460441.2023.2228199","volume":"18","author":"RJ Young","year":"2023","unstructured":"Young, R. J. Today\u2019s drug discovery and the shadow of the rule of 5. Expert Opin. Drug Discov. 18, 965\u2013972 (2023).","journal-title":"Expert Opin. Drug Discov."},{"key":"41159_CR101","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biomaterials.2017.03.028","volume":"130","author":"Z He","year":"2017","unstructured":"He, Z. et al. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin. Biomaterials 130, 28\u201341. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.028 (2017).","journal-title":"Biomaterials"},{"key":"41159_CR102","doi-asserted-by":"crossref","unstructured":"Brinks, H. L. & Eckhart, A. D. J. B. e. B. A.-M. B. o. D. Regulation of GPCR signaling in hypertension. 1802, 1268\u20131275 (2010).","DOI":"10.1016\/j.bbadis.2010.01.005"},{"key":"41159_CR103","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"MB \u010colovi\u0107","year":"2013","unstructured":"\u010colovi\u0107, M. B., Krsti\u0107, D. Z., Lazarevi\u0107-Pa\u0161ti, T. D., Bond\u017ei\u0107, A. M. & Vasi\u0107, V. M. Acetylcholinesterase inhibitors: Pharmacology and toxicology. Curr. Neuropharmacol. 11, 315 (2013).","journal-title":"Curr. Neuropharmacol."},{"key":"41159_CR104","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/jmr.951","volume":"22","author":"MC Jecklin","year":"2009","unstructured":"Jecklin, M. C., Schauer, S., Dumelin, C. E. & Zenobi, R. Label\u2010free determination of protein\u2013ligand binding constants using mass spectrometry and validation using surface plasmon resonance and isothermal titration calorimetry. J. Mol. Recognit. 22, 319\u2013329 (2009).","journal-title":"J. Mol. Recognit."},{"key":"41159_CR105","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02307-02318","author":"JB Bulitta","year":"2019","unstructured":"Bulitta, J. B. et al. Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/aac.02307-02318 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41159_CR106","doi-asserted-by":"publisher","first-page":"103845","DOI":"10.1016\/j.drudis.2023.103845","volume":"29","author":"A Acharya","year":"2024","unstructured":"Acharya, A., Yadav, M., Nagpure, M., Kumaresan, S. & Guchhait, S. K. Molecular medicinal insights into scaffold hopping-based drug discovery success. Drug Discov. Today 29, 103845. https:\/\/doi.org\/10.1016\/j.drudis.2023.103845 (2024).","journal-title":"Drug Discov. Today"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41159-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41159-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41159-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:03:21Z","timestamp":1776251001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41159-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41159"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41159-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ZB and IA are employed by Alpha Genomics Private Limited. IA is employed by Alpha Genomics Korea Co. Ltd. CRW is employed by Shing Huei Group, respectively. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12405"}}